BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 8246504)

  • 1. Quantitative study of the control of HIV-1 gene expression.
    Hammond BJ
    J Theor Biol; 1993 Jul; 163(2):199-221. PubMed ID: 8246504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on the effect of the combined expression of anti-tat and anti-rev genes on HIV-1 replication.
    Caputo A; Rossi C; Bozzini R; Betti M; Grossi MP; Barbanti-Brodano G; Balboni PG
    Gene Ther; 1997 Apr; 4(4):288-95. PubMed ID: 9176513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In silico mutagenesis of RNA splicing in HIV-1.
    Kim H; Yin J
    Biotechnol Bioeng; 2005 Sep; 91(7):877-93. PubMed ID: 15937951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of HTLV-I gene expression by HIV-1 Rev through an alternative RxRE-independent pathway mediated by the RU5 portion of the 5'-LTR.
    Kubota S; Furuta RA; Hatanaka M; Pomerantz RJ
    Biochem Biophys Res Commun; 1998 Feb; 243(1):79-85. PubMed ID: 9473483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multigene lentiviral vectors based on differential splicing and translational control.
    Zhu Y; Feuer G; Day SL; Wrzesinski S; Planelles V
    Mol Ther; 2001 Oct; 4(4):375-82. PubMed ID: 11592842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions of single and combined human immunodeficiency virus type 1 (HIV-1) DNA vaccines.
    Kjerrström A; Hinkula J; Engström G; Ovod V; Krohn K; Benthin R; Wahren B
    Virology; 2001 May; 284(1):46-61. PubMed ID: 11352667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular biology of human immunodeficiency virus type 1.
    Wang WK; Chen MY; Chuang CY; Jeang KT; Huang LM
    J Microbiol Immunol Infect; 2000 Sep; 33(3):131-40. PubMed ID: 11045374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear Factor 90, a cellular dsRNA binding protein inhibits the HIV Rev-export function.
    Urcuqui-Inchima S; Castaño ME; Hernandez-Verdun D; St-Laurent G; Kumar A
    Retrovirology; 2006 Nov; 3():83. PubMed ID: 17125513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potent inhibition of HIV-1 gene expression and TAT-mediated apoptosis in human T cells by novel mono- and multitarget anti-TAT/Rev/Env ribozymes and a general purpose RNA-cleaving DNA-enzyme.
    Unwalla H; Chakraborti S; Sood V; Gupta N; Banerjea AC
    Antiviral Res; 2006 Nov; 72(2):134-44. PubMed ID: 16790281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of HIV-1 envelope protein synthesis by Tat and Rev in 293 cells.
    Natarajan V; Radjendirane V; Salzman NP
    Virology; 1993 Sep; 196(1):122-9. PubMed ID: 8356789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the human immunodeficiency virus type 1 Rev protein on reporter gene and host T-cell gene expression.
    Bond VC; Huang MB; Person B; Hairston R; Ye XY; Saltarelli M
    Cell Mol Biol (Noisy-le-grand); 1997 Nov; 43(7):995-1005. PubMed ID: 9449532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High level inhibition of HIV replication with combination RNA decoys expressed from an HIV-Tat inducible vector.
    Fraisier C; Irvine A; Wrighton C; Craig R; Dzierzak E
    Gene Ther; 1998 Dec; 5(12):1665-76. PubMed ID: 10023446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complementary large loops determine the rate of RNA duplex formation in vitro in the case of an effective antisense RNA directed against the human immunodeficiency virus type 1.
    Homann M; Rittner K; Sczakiel G
    J Mol Biol; 1993 Sep; 233(1):7-15. PubMed ID: 8377194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sam68, RNA helicase A and Tap cooperate in the post-transcriptional regulation of human immunodeficiency virus and type D retroviral mRNA.
    Reddy TR; Tang H; Xu W; Wong-Staal F
    Oncogene; 2000 Jul; 19(32):3570-5. PubMed ID: 10951562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic stimulation of HIV-1 rev-dependent export of unspliced mRNA to the cytoplasm by hnRNP A1.
    Najera I; Krieg M; Karn J
    J Mol Biol; 1999 Feb; 285(5):1951-64. PubMed ID: 9925777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functionally-inactive and immunogenic Tat, Rev and Nef DNA vaccines derived from sub-Saharan subtype C human immunodeficiency virus type 1 consensus sequences.
    Scriba TJ; zur Megede J; Glashoff RH; Treurnicht FK; Barnett SW; van Rensburg EJ
    Vaccine; 2005 Jan; 23(9):1158-69. PubMed ID: 15629359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rates of shutdown of HIV-1 into latency: roles of the LTR and tat/rev/vpu gene region.
    Song SK; Li H; Cloyd MW
    Virology; 1996 Nov; 225(2):377-86. PubMed ID: 8918924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of stress protein (hsp27 and hsp70) expression in CD4+ lymphocytic cells following acute infection with human immunodeficiency virus type-1.
    Wainberg Z; Oliveira M; Lerner S; Tao Y; Brenner BG
    Virology; 1997 Jul; 233(2):364-73. PubMed ID: 9217059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of the small leader exons 2 and 3 on human immunodeficiency virus type 1 gene expression.
    Krummheuer J; Lenz C; Kammler S; Scheid A; Schaal H
    Virology; 2001 Aug; 286(2):276-89. PubMed ID: 11485396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of human immunodeficiency virus type 1 (HIV-1) replication by HIV-1-based lentivirus vectors expressing transdominant Rev.
    Mautino MR; Keiser N; Morgan RA
    J Virol; 2001 Apr; 75(8):3590-9. PubMed ID: 11264348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.